Summary:
A Phase 1, Randomized, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Fulvestrant (Test vs. Reference) Following Intramuscular Administration to the Gluteal Muscle in Healthy Female Subjects
Qualified Participants Must:
• Be a female in good health
•
Be age 40 to 75
•
Be at least 110 pounds
•
Be available for a 2 night stay and outpatient visits
Qualified Participants May Receive:
Compensation up to $6,400